Kshipra Medisciences Profile
Key Indicators
- Authorised Capital ₹ 4.00 M
- Paid Up Capital ₹ 4.00 M
- Company Age 8 Year, 4 Months
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 3.19 M
- Revenue Growth 19.39%
- Profit Growth -927.34%
- Ebitda -778.23%
- Net Worth -89.08%
- Total Assets -39.78%
About Kshipra Medisciences
Kshipra Medisciences Private Limited (KMPL) is a Private Limited Indian Non-Government Company incorporated in India on 06 October 2016 (Eight years and four months 4 days old ). Its registered office is in Thane, Maharashtra, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 4.00 M and a paid-up capital of Rs 4.00 M.
The company currently has active open charges totaling ₹3.19 M.
Vinod Methil, Devendra Dabak, and Aparna Methil serve as directors at the Company.
Company Details
-
Location
Thane, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74999MH2016PTC286619
-
Company No.
286619
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
06 Oct 2016
-
Date of AGM
30 Sep 2022
-
Date of Balance Sheet
31 Mar 2022
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Kshipra Medisciences?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vinod Methil
|
Director | 06-Oct-2016 | Current |
|
Aparna Methil
|
Director | 06-Oct-2016 | Current |
|
Devendra Dabak
|
Director | 06-Oct-2016 | Current |
Financial Performance of Kshipra Medisciences.
Kshipra Medisciences Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 19.39% increase. The company also saw a substantial fall in profitability, with a 927.34% decrease in profit. The company's net worth observed a substantial decline by a decrease of 89.08%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kshipra Medisciences?
In 2020, Kshipra Medisciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹3.19 M
₹0
Charges Breakdown by Lending Institutions
- Tjsb Sahakari Bank Limited : 0.32 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 11 Jan 2021 | Tjsb Sahakari Bank Limited | ₹0.19 M | Open |
| 28 Nov 2016 | Tjsb Sahakari Bank Limited | ₹3.00 M | Open |
How Many Employees Work at Kshipra Medisciences?
Unlock and access historical data on people associated with Kshipra Medisciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kshipra Medisciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kshipra Medisciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.